HR0588LRB103 35954 MST 66041 r

1
HOUSE RESOLUTION

 
2    WHEREAS, Many people living with serious mental illnesses,
3including bipolar disorder, major depressive disorder,
4schizophrenia, and schizoaffective disorder or
5gastrointestinal disorders such as gastroparesis, upset
6stomach, nausea, and vomiting, may be treated with medications
7that work as dopamine receptor blocking agents, including
8antipsychotics and antiemetics; and
 
9    WHEREAS, While ongoing treatment with these medications
10can be necessary, prolonged use is associated with tardive
11dyskinesia (TD), an involuntary movement disorder that is
12characterized by uncontrollable, abnormal, and repetitive
13movements of the face, torso, limbs, and fingers or toes; and
 
14    WHEREAS, Even mild symptoms of TD can impact people
15physically, socially, and emotionally; and
 
16    WHEREAS, It is estimated that TD affects approximately
17600,000 people in the United States, and approximately 65
18percent of people with TD have not been diagnosed, making it
19important to raise awareness about the symptoms; and
 
20    WHEREAS, It is important that people taking these
21medications be monitored for TD by a healthcare provider;

 

 

HR0588- 2 -LRB103 35954 MST 66041 r

1regular screening for TD is recommended by the American
2Psychiatric Association; and
 
3    WHEREAS, Clinical research has led to approval of
4treatments for adults with TD by the U.S. Food and Drug
5Administration, and recognition and treatment of TD can make a
6positive impact in the lives of many people experiencing
7psychotic and mood disorders; and
 
8    WHEREAS, The Illinois House of Representatives can utilize
9its position to raise awareness of TD among the public and
10medical community; therefore, be it
 
11    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE
12HUNDRED THIRD GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that
13we declare May 5-11, 2024 as "Tardive Dyskinesia Awareness
14Week" in the State of Illinois; and be it further
 
15    RESOLVED, That we encourage anyone experiencing
16uncontrollable, abnormal, and repetitive movements to consult
17their healthcare provider regarding their symptoms.